<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://aminowire.news/news/2026/11/nad-good-life-tirzepatide-plus-claims-lilly/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-04T16:13:52.000Z</news:publication_date>
      <news:title>NAD tells Good Life to drop compounded tirzepatide claims</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/11/nad-good-life-tirzepatide-plus-claims-lilly-16x9.jpg</image:loc></image:image>
  </url>
  <url>
    <loc>https://aminowire.news/news/2026/11/novo-q3-2026-raises-outlook-wegovy-pill/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-04T12:05:47.000Z</news:publication_date>
      <news:title>Novo raises 2026 outlook as Wegovy pill beats forecasts</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/11/novo-q3-2026-raises-outlook-wegovy-pill-16x9.jpg</image:loc></image:image>
  </url>
  <url>
    <loc>https://aminowire.news/news/2026/11/enhanced-six-peptides-clinician-access/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-03T14:12:18.000Z</news:publication_date>
      <news:title>Enhanced opens access to six HHS-listed peptides</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/11/enhanced-six-peptides-clinician-access-16x9.jpg</image:loc></image:image>
  </url>
  <url>
    <loc>https://aminowire.news/news/2026/11/futurhealth-inc-chapter-11-delaware/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-02T20:11:28.000Z</news:publication_date>
      <news:title>FuturHealth files Chapter 11 in Delaware</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/11/futurhealth-inc-chapter-11-delaware-16x9.jpg</image:loc></image:image>
  </url>
  <url>
    <loc>https://aminowire.news/news/2026/10/fda-warning-letter-ronanrx-compounded-glp-1-claims/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-04T16:13:52.000Z</news:publication_date>
      <news:title>FDA warns RonanRx over compounded GLP-1 marketing claims</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/10/fda-warning-letter-ronanrx-compounded-glp-1-claims-16x9.jpg</image:loc></image:image>
  </url>
  <url>
    <loc>https://aminowire.news/news/2026/10/pmda-alert-18-glp1-off-label-ketosis/</loc>
    <news:news>
      <news:publication><news:name>Amino Wire</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-03T02:05:16.000Z</news:publication_date>
      <news:title>PMDA warns on off-label GLP-1 slimming use</news:title>
    </news:news>
    <image:image><image:loc>https://aminowire.news/og/news/2026/10/pmda-alert-18-glp1-off-label-ketosis-16x9.jpg</image:loc></image:image>
  </url>
</urlset>
